As reviewed in recent posts, bipolar I and bipolar II disorders are associated with substantial functional impairments and increased mortality. Depressive episodes associated with bipolar disorder do ...

A new study led by University of Chicago researchers suggests a significant link between exposure to environmental pollution and an increase in the prevalence of neuropsychiatric disorders. Based on ...

A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...

Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...

October 9, 2012 (Montreal, Canada) — The first 6 months postpartum carry a significantly higher risk for women with major depressive disorder (MDD) to convert to bipolar disorder (BD) compared with ...

Subtle changes before a mood episode are often easiest to spot in hindsight. Here’s what to watch for. Managing a complex, ...

Publication bias, especially the lack of publication of negative treatment studies, is known to be a major problem in the medical literature. In particular, it appears that the pharmaceutical industry ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...

A recent study published in the Journal of Affective Disorders suggests that deep-seated negative beliefs formed in childhood play a role in how borderline personality traits appear in people with ...

Diagnosing bipolar disorder can be difficult. While it is not hard to distinguish between its two characteristic phases—the high spirits of mania and the low spirits of depression—it is challenging to ...